Captured By CONTU
When people think “regulatory capture” they normally think of some interest group pushing for legislation or regulations that benefit them at the expense of either the public or a rival. [...]
When people think “regulatory capture” they normally think of some interest group pushing for legislation or regulations that benefit them at the expense of either the public or a rival. [...]
News and Commentary In a summary of his forthcoming law review article, Sam Howard discusses the issues with Fair, Reasonable, and Non-Discriminatory (FRAND) patent licensing terms for standard essential patents. [...]
News and Commentary The Ninth Circuit has ruled that the elements of the biography of Tommy DeVito, one of the members of the band The Four Seasons, which were allegedly [...]
Rent Check It's unlikely the USPTO will grant a patent to a non-human inventor, and that's likely for the best. News and Commentary In a guest post on PatentlyO, [...]
The future is now, and once-hypothetical questions about the ability of artificial intelligence to produce a patentable invention are no longer so. Back in April, computer scientist Stephen Thaler’s creation, [...]
The “documentary” Plandemic and press conferences from “America’s Frontline Doctors,” to give two recent examples of COVID-19 misinformation, are unambiguously bad for the United States and the world. But they [...]
News and Commentary Kendrick Lamar is being sued by Terrance Hayes for the former's infringement Hayes' song "Loyalty" in a song of the same name. After initially prevailing in court [...]
We show how characterizing optimal patent policy for the pharmaceutical industry only requires information about generic producers' responses to changes in the effective duration and scope of new drug patents. [...]
Rent Check Moderna's failure to disclose the degree to which the government supported its vaccine is a scandal, but the silver lining to this incident is that it provides a [...]
Healthcare costs were a major issue during the Democratic primaries, but drug pricing (and patents more generally) received comparatively little attention. But, with Joe Biden’s selection of Kamala Harris as [...]